Posts Tagged ‘CYC’
What are the best ASX Health Stocks for 2024? Here are our top 4 picks!
As 2023 comes to an end, we thought we’d recap our best ASX Health Stocks for 2024! Traditionally, healthcare stocks are seen as defensive plays in dour markets. This has not proven to be the case in the last couple of years. Many ASX health stocks have suffered from high inflation and been unable to…
Read MoreFDA approval: Here’s how ASX biotechs and medtechs obtain it
Last week one of our favourite companies Cyclopharm (ASX:CYC) obtained FDA approval, a goal it had been striving for years to obtain and one that wasn’t reached without setbacks along the way. Many of our readers have asked about how FDA approval works and so we thought we would outline how this happens. For clarification, we…
Read MoreThe 3 best ASX biotech stocks for September!
Here are a trio of companies that we think are the best ASX biotech stocks for September! What are the Best stocks to invest in right now? Check our buy/sell stock tips The 3 best ASX biotech stocks for September! 1. Cyclopharm (ASX:CYC) As a stock that is in our view one…
Read MoreWhy did biotech shares underperform in 2022 and will they rebound with a vengence in 2023?
In the past year, biotech shares have performed poorly. Why has this been the case and will things be better in 2023? SIGN UP FOR THE STOCKS DOWN UNDER NEWSLETTER NOW! 1. Investor distaste for high risk assets For one, investors have been put off by the high risk associated with investing in…
Read MoreWhich ASX health stocks might get FDA approval in 2023?
It is the dream of many ASX health stocks and their investors for their company’s device or drug to be approved by the FDA, the USA’s medical regulator. This is because it unlocks the world’s largest healthcare market. Companies that achieved that feat recently included hearing aid company Nuheara (ASX:NUH), along with infant formula stocks…
Read More